Gene · 286
Papers2,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lichen Simplex Chronicus Itch: An Update. | Acta Derm Venereol | 2022 | 36250769 | PubTator, text mining | PubMed |
| Emerging role of IκBζ in inflammation: Emphasis on psoriasis. | Clin Transl Med | 2022 | 36245291 | PubTator, text mining | PubMed |
| DNA methylation at birth in monozygotic twins discordant for pediatric acute lymphoblastic leukemia. | Nat Commun | 2022 | 36241624 | PubTator, text mining | PubMed |
| Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis. | Redox Biol | 2022 | 36240620 | PubTator, text mining | PubMed |
| Implications of notch signaling in duchenne muscular dystrophy. | Front Physiol | 2022 | 36237531 | PubTator, text mining | PubMed |
| Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review. | Int J Mol Sci | 2022 | 36233046 | PubTator, text mining | PubMed |
| Novel GATA1 Variant Causing a Bleeding Phenotype Associated with Combined Platelet α-/δ-Storage Pool Deficiency and Mild Dyserythropoiesis Modified by a SLC4A1 Variant. | Cells | 2022 | 36231035 | PubTator, text mining | PubMed |
Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene. | Front Oncol | 2022 | 36212492 | PubTator, text mining | PubMed |
| Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease. | Front Neurosci | 2022 | 36203807 | PubTator, text mining | PubMed |
| Crosstalk between the Intestinal Virome and Other Components of the Microbiota, and Its Effect on Intestinal Mucosal Response and Diseases. | J Immunol Res | 2022 | 36203793 | PubTator, text mining | PubMed |
| Prediction of Alzheimer's Disease Using Patterns of Methylation Levels in Key Immunologic-Related Genes. | J Alzheimers Dis | 2022 | 36189598 | PubTator, text mining | PubMed |
| Heavy-load exercise in older adults activates vasculogenesis and has a stronger impact on muscle gene expression than in young adults. | Eur Rev Aging Phys Act | 2022 | 36182918 | PubTator, text mining | PubMed |
| The past and future of transient receptor potential: A scientometric analysis. | Medicine (Baltimore) | 2022 | 36181006 | PubTator, text mining | PubMed |
| Progress towards the UNAIDS 90-90-90 targets among persons aged 50 and older living with HIV in 13 African countries. | J Int AIDS Soc | 2022 | 36176030 | PubTator, text mining | PubMed |
| Unique structural features govern the activity of a human mitochondrial AAA+ disaggregase, Skd3. | Cell Rep | 2022 | 36170828 | PubTator, text mining | PubMed |
| Bcl-3 regulates the function of Th17 cells through raptor mediated glycolysis metabolism. | Front Immunol | 2022 | 36159779 | PubTator, text mining | PubMed |
| Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. | Genome Med | 2022 | 36153599 | PubTator, text mining | PubMed |
| DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. | Nat Commun | 2022 | 36153390 | PubTator, text mining | PubMed |
| Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions. | Int J Mol Sci | 2022 | 36142306 | PubTator, text mining | PubMed |
| Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy. | Cells | 2022 | 36139377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/286/papers?page=25